Nyxoah SA (NYXH)
4.78
-0.09
(-1.85%)
USD |
NASDAQ |
Dec 12, 14:46
Nyxoah EPS Diluted (Quarterly): -0.7359 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Galapagos NV | -3.584 |
| UCB SA | -- |
| Celyad Oncology SA | -- |
| Fagron NV | -- |
| MDxHealth SA | -0.1618 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.55M |
| Revenue (Quarterly) | 2.304M |
| Total Expenses (Quarterly) | 29.86M |
| Enterprise Value | 207.99M |
| Gross Profit Margin (Quarterly) | -12.52% |
| Profit Margin (Quarterly) | -1.20K% |
| Earnings Yield | -51.96% |
| Normalized Earnings Yield | -52.71 |